Literature DB >> 24277231

Molecular features of follicular variant papillary carcinoma of thyroid: comparison of areas with or without classical nuclear features.

Guven Guney1, Gaye Guler Tezel, Kemal Kosemehmetoglu, Engin Yilmaz, Serdar Balci, Reyhan Ersoy, Bekir Cakir, Gulnur Guler.   

Abstract

We aimed to compare the genetic background of different areas in follicular variant papillary thyroid carcinomas (FVPTC) with or without classical nuclear changes. Sixteen cases of FVPTC were included in our study. All tumors were well demarcated from surrounding thyroid tissue and had both areas with nuclear features (WNF) and areas without nuclear features (WONF) of papillary carcinoma. DNA is obtained by laser microdissection from WNF and WONF areas of each case. Point mutations for NRAS codon 61, HRAS codon 61, and BRAF were investigated by direct sequencing. In 11 cases, reverse transcription PCR was performed for the presence of PAX8-PPARɣ and RET/PTC1-3 gene rearrangements. Point mutation for NRAS codon 61 was also studied in 15 colloidal nodules. Seven cases (44 %) showed at least one mutation; two cases (13 %) revealed the same mutation in both WNF and WONF areas, while in the rest only WNF areas were mutated. None of the studied 11 cases demonstrated RET/PTC1-3 gene rearrangement and in only one case PAX8-PPARɣ gene rearrangement was found. Six cases (38 %) showed NRAS codon 61 mutation, involving only WNF areas in five cases and both WNF and WONF areas in one case. Neither HRAS codon 61 nor BRAF mutations were present. Fifteen colloidal nodules were also wild type for NRAS codon 61. Our findings suggest that NRAS codon 61 point mutations and PAX8-PPARɣ gene rearrangement play a role in the FVPTC pathogenesis and may be established before the morphological/phenotypical features fully develop.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24277231     DOI: 10.1007/s12022-013-9275-6

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  22 in total

Review 1.  Our approach to follicular-patterned lesions of the thyroid.

Authors:  Zubair W Baloch; Virginia A LiVolsi
Journal:  J Clin Pathol       Date:  2006-06-23       Impact factor: 3.411

Review 2.  Follicular patterned lesions of the thyroid gland: a practical algorithmic approach.

Authors:  Runjan Chetty
Journal:  J Clin Pathol       Date:  2011-05-18       Impact factor: 3.411

3.  Molecular and histopathologic characteristics of multifocal papillary thyroid carcinoma.

Authors:  Mona Bansal; Manoj Gandhi; Robert L Ferris; Marina N Nikiforova; Linwah Yip; Sally E Carty; Yuri E Nikiforov
Journal:  Am J Surg Pathol       Date:  2013-10       Impact factor: 6.394

4.  Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity.

Authors:  Jeffrey Liu; Bhuvanesh Singh; Giovanni Tallini; Diane L Carlson; Nora Katabi; Ashok Shaha; R Michael Tuttle; Ronald A Ghossein
Journal:  Cancer       Date:  2006-09-15       Impact factor: 6.860

5.  Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.

Authors:  Ana Rita Marques; Carla Espadinha; Ana L Catarino; Sónia Moniz; Teresa Pereira; Luís G Sobrinho; Valeriano Leite
Journal:  J Clin Endocrinol Metab       Date:  2002-08       Impact factor: 5.958

6.  PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses.

Authors:  Marina N Nikiforova; Paul W Biddinger; Christy M Caudill; Todd G Kroll; Yuri E Nikiforov
Journal:  Am J Surg Pathol       Date:  2002-08       Impact factor: 6.394

7.  Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations.

Authors:  Zhaowen Zhu; Manoj Gandhi; Marina N Nikiforova; Andrew H Fischer; Yuri E Nikiforov
Journal:  Am J Clin Pathol       Date:  2003-07       Impact factor: 2.493

8.  RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.

Authors:  Marina N Nikiforova; Roy A Lynch; Paul W Biddinger; Erik K Alexander; Gerald W Dorn; Giovanni Tallini; Todd G Kroll; Yuri E Nikiforov
Journal:  J Clin Endocrinol Metab       Date:  2003-05       Impact factor: 5.958

9.  Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance".

Authors:  N Paul Ohori; Marina N Nikiforova; Karen E Schoedel; Shane O LeBeau; Steven P Hodak; Raja R Seethala; Sally E Carty; Jennifer B Ogilvie; Linwah Yip; Yuri E Nikiforov
Journal:  Cancer Cytopathol       Date:  2010-02-25       Impact factor: 5.284

Review 10.  RET/PTC rearrangement in thyroid tumors.

Authors:  Yuri E Nikiforov
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

View more
  1 in total

1.  Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: A name change to Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features would help prevent overtreatment.

Authors:  Lester Dr Thompson
Journal:  Mod Pathol       Date:  2016-04-22       Impact factor: 7.842

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.